Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Autoimmune Diseases

  • News

    Anaerobically prepared donor FMT led to steroid-free remission of ulcerative colitis

    January 15, 2019

    Eight weeks after FMT, 32% of the donor group achieved steroid-free remission, compared with 9% of the autologous FMT group (odds ratio, 5; P = .03).

  • 1
    News

    FDA aims to boost safety of platelets for transfusion

    December 20, 2018

    The agency is seeking input on ways to decrease the risk of bacterial contamination in platelets stored for 5 and 7 days after collection.

  • 1
    News

    In-hospital blood saving strategy appears safe with anemia

    December 18, 2018

    Tolerating moderate in-hospital anemia did not negatively impact readmissions or mortality over 6 months.

  • 1
    News

    Preop anemia management saves blood, costs

    November 14, 2018

    BOSTON – Managing anemia prior to cardiac surgery saved a hospital more than $100,000 in transfusion costs in a pilot program.

  • 1
    News

    Five-year follow-up confirms safety of antibiotics for uncomplicated appendicitis

    September 25, 2018

    Antibiotic therapy offers a feasible alternative to appendectomy for the management of uncomplicated acute appendicitis.

  • 1
    News

    CDC concerned about multidrug-resistant Shigella

    June 7, 2018

    if clinicians need to use antibiotics to treat patients who have Shigella infections, they should monitor these patients carefully.

  • News

    Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk

    October 2, 2017

    Overall, the risk of major bleeds associated with NOACs was similar to the risk with conventional anticoagulants.

  • 1
    News

    Oral iron of no benefit in heart failure with iron deficiency

    May 16, 2017

    High-dose oral iron therapy doesn’t improve exercise capacity in the estimated 50% of patients with symptomatic heart failure who also have iron deficiency, according to a report published online May 16 in JAMA.Iron deficiency in patients with HF, regardless of their hemoglobin status, is ...

  • 1
    News

    PPIs triple heart failure hospitalization risk in atrial fib patients

    May 10, 2017

    PARIS – Atrial fib patients taking proton pump inhibitors, largely unnecessarily, have a far greater risk of hospitalization for an acute heart failure episode.

  • 1
    News

    Perioperative infliximab does not increase serious infection risk

    February 6, 2017

    The timing of a last dose of infliximab prior to elective knee or hip replacement surgery does not appear to affect the 30-day risk of serious infection after surgery.

Previous1 … 5 6 7
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences